Volume 98, Issue 2 pp. 488-491
Full Access

Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma

Michael Probst-Kepper

Michael Probst-Kepper

Department of Haematology and Oncology,

Search for more papers by this author
Andres Schrader

Andres Schrader

Department of Haematology and Oncology,

Search for more papers by this author
Jan Buer

Jan Buer

Department of Haematology and Oncology,

Search for more papers by this author
Jens Grosse

Jens Grosse

Department of Haematology and Oncology,

Search for more papers by this author
Matthias Volkenandt

Matthias Volkenandt

Department of Dermatology, Ludwig-Maximilians-Universität, München, Germany

Search for more papers by this author
Hans-Joachim Illiger

Hans-Joachim Illiger

Department Haematology and Oncology, Städtische Kliniken Oldenburg,

Search for more papers by this author
Bernd Metzner

Bernd Metzner

Department Haematology and Oncology, Städtische Kliniken Oldenburg,

Search for more papers by this author
Janosch Kadar

Janosch Kadar

Department of Transfusion Medicine, Medizinische Hochschule Hannover,

Search for more papers by this author
Stefan Duensing

Stefan Duensing

Department of Haematology and Oncology,

Search for more papers by this author
Bernd Hertenstein

Bernd Hertenstein

Department of Haematology and Oncology,

Search for more papers by this author
Arnold Ganser

Arnold Ganser

Department of Haematology and Oncology,

Search for more papers by this author
Jens Atzpodien

Jens Atzpodien

Department of Haematology and Oncology,

Search for more papers by this author
First published: 29 October 2003
Citations: 3
Dr Jens Atzpodien Department of Haematology and Oncology, Medizinische Hochschule Hannover, D-30623 Hannover, Germany.

Abstract

The detection of melanocyte-specific messenger RNA in patients with malignant melanoma suggests the potential contamination of peripheral blood stem cell (PBSC) harvests by neoplastic cells. In this study, the melanocyte-specific transcripts of tyrosinase and Melan-A/MART-1 were used to detect neoplastic cells in PBSC harvests of nine metastatic malignant melanoma patients. Only one patient’s PBSC harvest tested positive for tyrosinase. All harvests were negative for Melan-A/MART-1. Our results suggest that contamination of PBSC harvests with neoplastic cells may not contribute to disease progression following high-dose chemotherapy in advanced malignant melanoma.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.